{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:39:59Z","timestamp":1794973199397,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11887-x","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T20:42:09Z","timestamp":1753735329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Regulatory B cells drive immune evasion in the tumor microenvironment and are involved peritoneal metastasis in gastric cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuta","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2871-9549","authenticated-orcid":false,"given":"Jun","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikatsu","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Horii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiyo","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Inaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"11887_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"11887_CR2","doi-asserted-by":"publisher","unstructured":"Shirao, K. et al. Randomized phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in Far advanced gastric cancer with peritoneal metastasis (JCOG0106). Jpn J. Clin. Oncol. 43, 972\u2013980. https:\/\/doi.org\/10.1093\/jjco\/hyt114 (2013).","DOI":"10.1093\/jjco\/hyt114"},{"key":"11887_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/s1470-2045(14)70420-6","volume":"15","author":"H Wilke","year":"2014","unstructured":"Wilke, H. et al. Ramucirumab plus Paclitaxel versus placebo plus Paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol. 15, 1224\u20131235. https:\/\/doi.org\/10.1016\/s1470-2045(14)70420-6 (2014).","journal-title":"Lancet Oncol."},{"key":"11887_CR4","doi-asserted-by":"publisher","unstructured":"Janjigian, Y. Y. et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet (London England). 398, 27\u201340. https:\/\/doi.org\/10.1016\/s0140-6736(21)00797-2 (2021).","DOI":"10.1016\/s0140-6736(21)00797-2"},{"key":"11887_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/s1470-2045(21)00692-6","volume":"23","author":"YK Kang","year":"2022","unstructured":"Kang, Y. K. et al. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 23, 234\u2013247. https:\/\/doi.org\/10.1016\/s1470-2045(21)00692-6 (2022).","journal-title":"Lancet Oncol."},{"key":"11887_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/s41416-020-0975-7","volume":"123","author":"T Hagi","year":"2020","unstructured":"Hagi, T. et al. Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer. Br. J. Cancer. 123, 965\u2013972. https:\/\/doi.org\/10.1038\/s41416-020-0975-7 (2020).","journal-title":"Br. J. Cancer"},{"key":"11887_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10120-021-01237-x","volume":"25","author":"Y Takahashi","year":"2022","unstructured":"Takahashi, Y. et al. Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08). Gastric Cancer: Official J. Int. Gastric Cancer Association Japanese Gastric Cancer Association. 25, 235\u2013244. https:\/\/doi.org\/10.1007\/s10120-021-01237-x (2022).","journal-title":"Gastric Cancer: Official J. Int. Gastric Cancer Association Japanese Gastric Cancer Association"},{"key":"11887_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1517\/14728222.2014.955794","volume":"18","author":"BS Henick","year":"2014","unstructured":"Henick, B. S., Herbst, R. S. & Goldberg, S. B. The PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer. Expert Opin. Ther. Targets. 18, 1407\u20131420. https:\/\/doi.org\/10.1517\/14728222.2014.955794 (2014).","journal-title":"Expert Opin. Ther. Targets"},{"key":"11887_CR9","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1186\/s12885-020-07477-x","volume":"20","author":"D Fujimori","year":"2020","unstructured":"Fujimori, D. et al. Established fibrous peritoneal metastasis in an immunocompetent mouse model similar to clinical immune microenvironment of gastric cancer. BMC cancer. 20, 1014. https:\/\/doi.org\/10.1186\/s12885-020-07477-x (2020).","journal-title":"BMC cancer"},{"key":"11887_CR10","doi-asserted-by":"publisher","first-page":"582657","DOI":"10.3389\/fimmu.2020.582657","volume":"11","author":"J Shang","year":"2020","unstructured":"Shang, J., Zha, H. & Sun, Y. Phenotypes, functions, and clinical relevance of regulatory B cells in Cancer. Front. Immunol. 11, 582657. https:\/\/doi.org\/10.3389\/fimmu.2020.582657 (2020).","journal-title":"Front. Immunol."},{"key":"11887_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.it.2007.10.004","volume":"29","author":"C Mauri","year":"2008","unstructured":"Mauri, C. & Ehrenstein, M. R. The \u2018short\u2019 history of regulatory B cells. Trends Immunol. 29, 34\u201340. https:\/\/doi.org\/10.1016\/j.it.2007.10.004 (2008).","journal-title":"Trends Immunol."},{"key":"11887_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05137.x","volume":"1183","author":"DJ DiLillo","year":"2010","unstructured":"DiLillo, D. J., Matsushita, T. & Tedder, T. F. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. N. Y. Acad. Sci. 1183, 38\u201357. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05137.x (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"11887_CR13","doi-asserted-by":"publisher","unstructured":"Mizoguchi, A. & Bhan, A. K. A case for regulatory B cells. J. Immunol. Baltimore, Md.: 1950). 176, 705\u2013710. https:\/\/doi.org\/10.4049\/jimmunol.176.2.705 (2006).","DOI":"10.4049\/jimmunol.176.2.705"},{"key":"11887_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","volume":"28","author":"K Yanaba","year":"2008","unstructured":"Yanaba, K. et al. A regulatory B cell subset with a unique CD1dhiCD5\u2009+\u2009phenotype controls T cell-dependent inflammatory responses. Immunity 28, 639\u2013650. https:\/\/doi.org\/10.1016\/j.immuni.2008.03.017 (2008).","journal-title":"Immunity"},{"key":"11887_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0008-8749(84)90242-9","volume":"83","author":"T Shimamura","year":"1984","unstructured":"Shimamura, T., Habu, S., Hashimoto, K. & Sasaki, S. Feedback suppression of the immune response in vivo. III. Lyt-1\u2009+\u2009B cells are suppressor-inducer cells. Cell. Immunol. 83, 221\u2013224. https:\/\/doi.org\/10.1016\/0008-8749(84)90242-9 (1984).","journal-title":"Cell. Immunol."},{"key":"11887_CR16","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.jaci.2015.12.1319","volume":"138","author":"T Matsushita","year":"2016","unstructured":"Matsushita, T. et al. A novel Splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase-Akt pathway activation. J. Allergy Clin. Immunol. 138, 1170\u201382e9. https:\/\/doi.org\/10.1016\/j.jaci.2015.12.1319 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"11887_CR17","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jid.2019.02.016","volume":"139","author":"T Kobayashi","year":"2019","unstructured":"Kobayashi, T. et al. Regulatory B1a cells suppress melanoma tumor immunity via IL-10 production and inhibiting T helper type 1 cytokine production in tumor-Infiltrating CD8(+) T cells. J. Invest. Dermatol. 139, 1535\u201344e1. https:\/\/doi.org\/10.1016\/j.jid.2019.02.016 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"11887_CR18","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/cas.13569","volume":"109","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto, M. et al. Established gastric cancer cell lines transplantable into C57BL\/6 mice show fibroblast growth factor receptor 4 promotion of tumor growth. Cancer Sci. 109, 1480\u20131492. https:\/\/doi.org\/10.1111\/cas.13569 (2018).","journal-title":"Cancer Sci."},{"key":"11887_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1525-1438.2002.01093.x","volume":"12","author":"B Melichar","year":"2018","unstructured":"Melichar, B. & Freedman, R. S. Immunology of the peritoneal cavity: relevance for host-tumor relation. Int. J. Gynecol. Cancer:official J. Int. Gynecol. Cancer Soc. 12, 3\u201317. https:\/\/doi.org\/10.1046\/j.1525-1438.2002.01093.x (2018).","journal-title":"Int. J. Gynecol. Cancer:official J. Int. Gynecol. Cancer Soc."},{"key":"11887_CR20","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.ajpath.2013.06.030","volume":"183","author":"AL Sedlacek","year":"2013","unstructured":"Sedlacek, A. L. et al. Generation of a dual-functioning antitumor immune response in the peritoneal cavity. Am. J. Pathol. 183, 1318\u20131328. https:\/\/doi.org\/10.1016\/j.ajpath.2013.06.030 (2013).","journal-title":"Am. J. Pathol."},{"key":"11887_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00018-017-2663-1","volume":"75","author":"J Miku\u0142a-Pietrasik","year":"2018","unstructured":"Miku\u0142a-Pietrasik, J., Uruski, P., Tykarski, A. & Ksi\u0105\u017cek, K. The peritoneal soil for a cancerous seed: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cell. Mol. Life Sci. 75, 509\u2013525. https:\/\/doi.org\/10.1007\/s00018-017-2663-1 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"11887_CR22","doi-asserted-by":"publisher","first-page":"e22141","DOI":"10.1371\/journal.pone.0022141","volume":"6","author":"A Cassado Ados","year":"2011","unstructured":"Cassado Ados, A. et al. Cellular renewal and improvement of local cell effector activity in peritoneal cavity in response to infectious stimuli. PloS One. 6, e22141. https:\/\/doi.org\/10.1371\/journal.pone.0022141 (2011).","journal-title":"PloS One"},{"key":"11887_CR23","doi-asserted-by":"publisher","first-page":"969468","DOI":"10.3389\/fimmu.2022.969468","volume":"13","author":"K Takahashi","year":"2022","unstructured":"Takahashi, K. et al. Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer. Front. Immunol. 13, 969468. https:\/\/doi.org\/10.3389\/fimmu.2022.969468 (2022).","journal-title":"Front. Immunol."},{"key":"11887_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/2326-6066.CIR-19-0349","volume":"8","author":"B Mirllekar","year":"2020","unstructured":"Mirllekar, B. et al. B cell\u2013derived IL35 drives STAT3-dependent CD8\u2009+\u2009T-cell exclusion in pancreatic cancer. Cancer Immunol. Res. 8, 292\u2013308. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0349 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"11887_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/cei\/uxac029","volume":"209","author":"P Blair","year":"2022","unstructured":"Fabian Flores-Borja & Blair, P. Mechanisms of induction of regulatory B cells in the tumour microenvironment and their contribution to immunosuppression and pro-tumour responses. Clin. Exp. Immunol. 209, 33\u201345. https:\/\/doi.org\/10.1093\/cei\/uxac029 (2022).","journal-title":"Clin. Exp. Immunol."},{"key":"11887_CR26","doi-asserted-by":"publisher","first-page":"611795","DOI":"10.3389\/fimmu.2021.611795","volume":"12","author":"D Catalan","year":"2021","unstructured":"Catalan, D. et al. Immunosuppressive mechanisms of regulatory B cells. Front. Immunol. 12, 611795. https:\/\/doi.org\/10.3389\/fimmu.2021.611795 (2021).","journal-title":"Front. Immunol."},{"key":"11887_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/CJI.0b013e318189f13c","volume":"32","author":"TA Moo-Young","year":"2009","unstructured":"Moo-Young, T. A. et al. Tumor derived TGF-beta mediates conversion of CD4\u2009+\u2009Foxp3\u2009+\u2009regulatory T cells in a murine model of pancreas cancer. J. Immunother. 32, 12\u201321. https:\/\/doi.org\/10.1097\/CJI.0b013e318189f13c (2009).","journal-title":"J. Immunother."},{"key":"11887_CR28","doi-asserted-by":"publisher","first-page":"106999","DOI":"10.1016\/j.oraloncology.2024.106999","volume":"108","author":"Y Ge","year":"2024","unstructured":"Ge, Y. et al. Immunoinhibitory effects of hypoxia-driven reprogramming of EGR1hi and EGR3 positive B cells in the nasopharyngeal carcinoma microenvironment. Oral Oncol. 108, 106999. https:\/\/doi.org\/10.1016\/j.oraloncology.2024.106999 (2024).","journal-title":"Oral Oncol."},{"key":"11887_CR29","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1245\/s10434-022-12465-5","volume":"30","author":"T Aoki","year":"2023","unstructured":"Aoki, T. et al. Hypoxia-Induced CD36 expression in gastric Cancer cells promotes peritoneal metastasis via fatty acid uptake. Ann. Surg. Oncol. 30, 3125\u20133136. https:\/\/doi.org\/10.1245\/s10434-022-12465-5 (2023).","journal-title":"Ann. Surg. Oncol."},{"key":"11887_CR30","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.4049\/jimmunol.0900185","volume":"183","author":"R Madan","year":"2009","unstructured":"Madan, R. et al. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 183, 2312\u20132320. https:\/\/doi.org\/10.4049\/jimmunol.0900185 (2009).","journal-title":"Jornal Immunol."},{"key":"11887_CR31","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/cmi.2017.35","volume":"14","author":"A Sarvaria","year":"2017","unstructured":"Sarvaria, A., Madrigal, J. A. & Saudemont, A. B cell regulation in cancer and anti-tumor immunity. Cell Mol. Immunol. 14, 662\u2013674. https:\/\/doi.org\/10.1038\/cmi.2017.35 (2017).","journal-title":"Cell Mol. Immunol."},{"key":"11887_CR32","doi-asserted-by":"publisher","first-page":"13083","DOI":"10.1038\/s41598-019-49581-4","volume":"9","author":"Y Murakami","year":"2019","unstructured":"Murakami, Y. et al. Increased regulatory B cells are involved in immune evasion in patients with gastric cancer. Sci. Rep. 9, 13083. https:\/\/doi.org\/10.1038\/s41598-019-49581-4 (2019).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11887-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11887-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11887-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:05:34Z","timestamp":1753916734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11887-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11887"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11887-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27499"}}